These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 11708868)

  • 1. Anthracycline-induced cardiac injury using a cardiac cell line: potential for gene therapy studies.
    L'Ecuyer T; Horenstein MS; Thomas R; Vander Heide R
    Mol Genet Metab; 2001 Nov; 74(3):370-9. PubMed ID: 11708868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plantainoside D protects adriamycin-induced apoptosis in H9c2 cardiac muscle cells via the inhibition of ROS generation and NF-kappaB activation.
    Kim DS; Woo ER; Chae SW; Ha KC; Lee GH; Hong ST; Kwon DY; Kim MS; Jung YK; Kim HM; Kim HK; Kim HR; Chae HJ
    Life Sci; 2007 Jan; 80(4):314-23. PubMed ID: 17034819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute administration of epirubicin induces myocardial depression in isolated rat heart and production of radical species evaluated by electron spin resonance spectroscopy.
    Delemasure S; Sicard P; Lauzier B; Moreau D; Vergely C; Rochette L
    J Cardiovasc Pharmacol; 2007 Dec; 50(6):647-53. PubMed ID: 18091581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procyanidins produce significant attenuation of doxorubicin-induced cardiotoxicity via suppression of oxidative stress.
    Li W; Xu B; Xu J; Wu XL
    Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):192-7. PubMed ID: 19143757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin protection against lethal myocyte injury induced by doxorubicin as reflected by effects on mitochondrial membrane potential.
    Xu M; Ashraf M
    J Mol Cell Cardiol; 2002 Jan; 34(1):75-9. PubMed ID: 11812166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heat shock protein 27 regulates oxidative stress-induced apoptosis in cardiomyocytes: mechanisms via reactive oxygen species generation and Akt activation.
    Liu L; Zhang XJ; Jiang SR; Ding ZN; Ding GX; Huang J; Cheng YL
    Chin Med J (Engl); 2007 Dec; 120(24):2271-7. PubMed ID: 18167217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NADPH oxidases participate to doxorubicin-induced cardiac myocyte apoptosis.
    Gilleron M; Marechal X; Montaigne D; Franczak J; Neviere R; Lancel S
    Biochem Biophys Res Commun; 2009 Oct; 388(4):727-31. PubMed ID: 19699179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4'-Epidoxorubicin to re-explore anthracycline degradation in cardiomyocytes.
    Menna P; Salvatorelli E; Minotti G
    Chem Res Toxicol; 2009 Jun; 22(6):978-83. PubMed ID: 19397277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of rosmarinic acid on adriamycin-induced apoptosis in H9c2 cardiac muscle cells by inhibiting reactive oxygen species and the activations of c-Jun N-terminal kinase and extracellular signal-regulated kinase.
    Kim DS; Kim HR; Woo ER; Hong ST; Chae HJ; Chae SW
    Biochem Pharmacol; 2005 Oct; 70(7):1066-78. PubMed ID: 16102732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hexane/ethanol extract of Glycyrrhiza uralensis licorice suppresses doxorubicin-induced apoptosis in H9c2 rat cardiac myoblasts.
    Choi HJ; Seon MR; Lim SS; Kim JS; Chun HS; Park JH
    Exp Biol Med (Maywood); 2008 Dec; 233(12):1554-60. PubMed ID: 18849542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stable overexpression of human metallothionein-IIA in a heart-derived cell line confers oxidative protection.
    Xue W; Liu Q; Cai L; Wang Z; Feng W
    Toxicol Lett; 2009 Jul; 188(1):70-6. PubMed ID: 19433272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protective effect of cardiac gene transfer of CuZn-sod in comparison with the cardioprotector monohydroxyethylrutoside against doxorubicin-induced cardiotoxicity in cultured cells.
    Abou El Hassan MA; Heijn M; Rabelink MJ; van der Vijgh WJ; Bast A; Hoeben RC
    Cancer Gene Ther; 2003 Apr; 10(4):270-7. PubMed ID: 12679799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of anthracycline-induced cardiotoxicity and its prevention.
    Horenstein MS; Vander Heide RS; L'Ecuyer TJ
    Mol Genet Metab; 2000; 71(1-2):436-44. PubMed ID: 11001837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthracycline toxicity is potentiated by iron and inhibited by deferoxamine: studies in rat heart cells in culture.
    Hershko C; Link G; Tzahor M; Kaltwasser JP; Athias P; Grynberg A; Pinson A
    J Lab Clin Med; 1993 Sep; 122(3):245-51. PubMed ID: 8409700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of muscle gene expression by oxidative stress in cardiac cells.
    Torti SV; Akimoto H; Lin K; Billingham ME; Torti FM
    J Mol Cell Cardiol; 1998 Jun; 30(6):1173-80. PubMed ID: 9689591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of stress responses of H9c2 rat cardiomyoblasts following treatment with doxorubicin and tBOOH.
    Döhrmann M; Schorr A; Hülsenbeck J; Rasmussen TL; Issinger OG; Fritz G
    Exp Cell Res; 2012 Apr; 318(6):779-88. PubMed ID: 22265794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acetylcysteine prevents glucose/glucose oxidase-induced oxidative stress, mitochondrial damage and apoptosis in H9c2 cells.
    Kumar S; Sitasawad SL
    Life Sci; 2009 Mar; 84(11-12):328-36. PubMed ID: 19159629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of several cytochrome P450 genes by doxorubicin in H9c2 cells.
    Zordoky BN; El-Kadi AO
    Vascul Pharmacol; 2008; 49(4-6):166-72. PubMed ID: 18707023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin induces cardiomyocyte dysfunction via a p38 MAP kinase-dependent oxidative stress mechanism.
    Wold LE; Aberle NS; Ren J
    Cancer Detect Prev; 2005; 29(3):294-9. PubMed ID: 15936597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of 1C aldoketoreductases and other drug dose-dependent genes upon acquisition of anthracycline resistance.
    Veitch ZW; Guo B; Hembruff SL; Bewick AJ; Heibein AD; Eng J; Cull S; Maclean DA; Parissenti AM
    Pharmacogenet Genomics; 2009 Jun; 19(6):477-88. PubMed ID: 19440163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.